Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium (Q45878922)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium |
scientific article |
Statements
1 reference
Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium (English)
1 reference
Sumanth C Suresh
Vaithinathan Selvaraju
Mahesh Thirunavukkarasu
Joshua W Goldman
Aaftab Husain
J Alexander Palesty
Juan A Sanchez
15 August 2015
1 reference